📰 Tim Oldham News
Tim Oldham News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tim Oldham. Real-time updates on events, politics, business and more.
April 9, 2024
#industry #news #UK #2024 #insights #zenopa #recruitment #SYNthesis #BioVentures #AdAlta #Collaborate #Enhance #Cancer #Immunotherapy #pharmaceutical
November 14, 2023
It’s been a difficult quarter for the biotech sector, with economies struggling to recover from high inflation making for a small appetite for risk. The ASX...
November 7, 2023
Clinical-stage drug discovery company AdAlta Ltd (ASX:1AD) has raised $1.65 million in an oversubscribed placement to institutional and sophisticated...
November 4, 2023
AdAlta Ltd (ASX:1AD) has launched a placement to sophisticated and professional investors to raise up to A$1.23 million at an issue price of 2 cents per new...
October 23, 2023
AdAlta Ltd (ASX:1AD) CEO Dr Tim Oldham speaks with Proactive after announcing all healthy volunteers in its AD-214 Phase I extension study have successfully...
October 18, 2023
AdAlta Ltd (ASX:1AD) has received its FY2023 Research and Development Tax Incentive (RDTI) refund of $2,350,940 from the Australian Government. The...
September 26, 2023
The ASX cared little for Wall Street’s overnight rally, with the S&P/ASX200 lowering its colours by 34.10 points or 0.48% to 7,042.40. The index has...
September 26, 2023
AdAlta Ltd (ASX:1AD) CEO Dr Tim Oldham speaks with Proactive after receiving the results of dose simulation studies that support the potential efficacy of...
September 25, 2023
AdAlta Ltd (ASX:1AD) has received results of dose simulation studies that support the potential efficacy of its i-body drug candidate AD-214 in fibrotic...
September 21, 2023
AdAlta Ltd (ASX:1AD) CEO Dr Tim Oldham tells Proactive the company has wrapped up the enrolment of healthy volunteers for its AD-214 Phase 1 extension...